Pfizer (PFE) CEO Albert Bourla purchases 38,000 company shares in open-market buy
Rhea-AI Filing Summary
Pfizer Inc. Chairman & CEO Albert Bourla reported an open-market purchase of 38,000 shares of Pfizer common stock on 2026-08-12 at $26.34 per share. Following this transaction, he holds 429,173 shares directly and 6,382 shares indirectly through a Rule 16b-3 Plan.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 38,000 shares
Net Buy
2 txns
Insider
BOURLA ALBERT
Role
Chairman & CEO
Bought
38,000 shs ($1.00M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 38,000 | $26.34 | $1.00M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 429,173 shares (Direct);
Common Stock — 6,382 shares (Indirect, By Rule 16b-3 Plan)
Key Figures
Shares purchased: 38,000 shares
Purchase price: $26.34 per share
Direct holdings after transaction: 429,173 shares
+2 more
5 metrics
Shares purchased
38,000 shares
Common Stock bought on 2026-08-12
Purchase price
$26.34 per share
Price for the 38,000-share Common Stock purchase
Direct holdings after transaction
429,173 shares
Common Stock directly owned by Albert Bourla after purchase
Indirect holdings after transaction
6,382 shares
Common Stock indirectly owned via Rule 16b-3 Plan
Net buy shares
38,000 shares
Net common shares bought across reported transactions
Key Terms
Rule 16b-3 Plan, Common Stock, Form 4
3 terms
Rule 16b-3 Plan regulatory
"Indirect ownership described as "By Rule 16b-3 Plan""
Common Stock financial
"security_title listed as "Common Stock" for the transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"Insider transaction reported on SEC Form 4"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What did Pfizer (PFE) CEO Albert Bourla report in this Form 4?
Albert Bourla reported a purchase of 38,000 shares of Pfizer common stock on 2026-08-12 at $26.34 per share, increasing his directly held Pfizer share position.
Was the Pfizer (PFE) insider transaction by Albert Bourla a buy or a sell?
The Form 4 shows a buy transaction: Albert Bourla purchased 38,000 Pfizer shares at $26.34 per share in an open-market or private transaction coded as a purchase.
Does Albert Bourla have indirect holdings of Pfizer (PFE) stock?
Yes. In addition to his direct holdings, the Form 4 reports 6,382 Pfizer shares held indirectly by Albert Bourla through a Rule 16b-3 Plan, which is a plan-based form of ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
